SCHEMBL15322640

SCHEMBL15322640

O=[N+]([O-])c1ccc(C#CC2CC2)c(F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.44
HIF1A Q16665 1/20 0.44
KMT2A Q03164 2/20 0.40
HSP90AA1 P07900 1/20 0.39
P2RY6 Q15077 1/20 0.38
LMNA P02545 4/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
VCAM1 P19320 1/20 0.36
GPR3 P46089 1/20 0.36
TSHR P16473 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
HSD17B10 Q99714 1/20 0.35
HSPB1 P04792 2/20 0.35
MAPT P10636 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
CRHBP P24387 1/20 0.35
CRHR2 Q13324 1/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4174336 0.88 ALDH1A1 (0.47) ALDH1A1HIF1AKMT2AHSP90AA1P2RY6
SCHEMBL1465043 0.80 TDP1 (0.46) ALDH1A1KMT2AHSP90AA1LMNAVCAM1
SCHEMBL22091313 0.77 CYP3A4 (0.44) ALDH1A1KMT2AHSP90AA1LMNATSHR
SCHEMBL25837938 0.74 VCAM1 (0.59) ALDH1A1HIF1AKMT2ALMNAVCAM1
SCHEMBL361867 0.74 VCAM1 (0.59) ALDH1A1HIF1AKMT2ALMNAVCAM1
Fluoride SCHEMBL28618487 0.72 VCAM1 (0.57) ALDH1A1HIF1AKMT2ALMNAVCAM1
SCHEMBL25886876 0.72 HSP90AA1 (0.51) ALDH1A1HIF1AKMT2AHSP90AA1LMNA
SCHEMBL28619044 0.72 ALDH1A1 (0.51) ALDH1A1KMT2AHSP90AA1P2RY6LMNA
SCHEMBL30152214 0.71 CA12 (0.45) ALDH1A1HIF1AKMT2AHSP90AA1LMNA
SCHEMBL15322909 0.70 ATM (0.49) ALDH1A1HIF1AP2RY6LMNAVCAM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013153535-A1 TRICYCLIC COMPOUNDS AS mPGES-1 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2013-10-17 WO disclosed
WO-2013153535-A1 TRICYCLIC COMPOUNDS AS mPGES-1 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2013-10-17 WO disclosed